Assertio Therapeutics, Inc. buy elfe
Start price
12.01.16
/
50%
€13.58
Target price
10.04.17
€25.26
Performance (%)
-8.64%
End price
10.04.17
€12.40
Summary
This prediction ended on 10.04.17 with a price of €12.40. With a performance of -8.64%, the BUY prediction for Assertio Therapeutics, Inc. by elfe closed slightly in the red. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Assertio Therapeutics, Inc. | -2.667% | -2.667% | -87.813% | -92.074% |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% | 54.489% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% | 85.552% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% | 55.407% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% | 62.988% |
Comments by elfe for this prediction
In the thread Assertio Therapeutics, Inc. diskutieren
hartmut.kaiser.790 stimmt der Buy-Einschätzung von Subdi zu
hartmut.kaiser.790 stimmt am 12.01.2016 der Buy-Einschätzung von Subdi mit dem Kursziel 28$ zu.Überschrift: Subdi stimmt der Buy-Einschätzung von datca zu
(Laufzeit überschritten)